Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.
about
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinomaLow interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists.Health-related quality of life and cancer clinical trials.Platinum-induced neurotoxicity and preventive strategies: past, present, and futureComparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancerIncident Learning and Failure-Mode-and-Effects-Analysis Guided Safety Initiatives in Radiation MedicineAdverse symptom event reporting by patients vs clinicians: relationships with clinical outcomesNCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach.Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.EORTC 10941: A phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer.Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience.Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.Advantages and Adversities of the Weighted Toxicity ScoreChemotherapy-Induced Neuropathy
P2860
Q27488232-C1C3BDFA-A577-45DB-BE61-3F8261BB32FBQ33180637-B5264921-702B-4205-8887-45BADFF9E3F1Q34507381-6887BF10-1C83-437A-977C-4C923B1C796AQ34772278-46AD788E-8538-4F21-BC38-A272B0577594Q35076356-3EA86A63-CE01-4F78-B85F-93D680ADB814Q35345734-EA8D4BD3-9E40-4829-9564-D57D40DD5B43Q36002272-171C10A6-03B6-44F4-A095-2FDA2B114FECQ36295002-F855BFBE-1CB3-4C10-B351-3B5AB76E07AFQ36551631-2583DA07-46DD-4242-BDB5-A54BDE4D99DEQ36814437-1E0F7C72-5E38-416E-B829-C4C32A568A61Q37394109-850914A9-8220-41CE-B36E-0ECCC530AC9CQ37452740-5056DF1D-1BBB-4C00-AD3B-12FD744D6F85Q37763136-605D66D8-8B51-480D-BCB2-91E1391B8A11Q37900261-4319BA0C-9BAB-4FCE-8E54-54BF92D01F0DQ40550975-128C6034-FDF8-4890-A840-0C445B7661D5Q40682598-80A4F364-7341-4517-A4AD-E7196C77775AQ40761878-0CE41783-CF2E-472B-B3B7-A176BDE6E6D5Q42198834-BD1594D8-5192-4F76-84FC-C4A7002DD563Q42936157-2F0D9645-AB89-499A-B467-CB0F1704B184Q43209150-BD2902C5-D9B3-4E08-BC2C-0696D90E1ADEQ51005334-FBA5283B-4417-428A-8E34-A63D7BEE2448Q53474437-33057513-69BF-4D90-9258-64F05F166A30Q57462226-AAD65A5A-ED64-4DF6-A828-5DA087D1E1A4Q58874394-9BDBB8DF-8881-4922-879B-FE1417F7E065
P2860
Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Assessing the reliability of t ...... or interpreting toxicity data.
@ast
Assessing the reliability of t ...... or interpreting toxicity data.
@en
type
label
Assessing the reliability of t ...... or interpreting toxicity data.
@ast
Assessing the reliability of t ...... or interpreting toxicity data.
@en
prefLabel
Assessing the reliability of t ...... or interpreting toxicity data.
@ast
Assessing the reliability of t ...... or interpreting toxicity data.
@en
P356
P1476
Assessing the reliability of t ...... for interpreting toxicity data
@en
P2093
M D Brundage
P304
P356
10.1093/JNCI/85.14.1138
P407
P577
1993-07-01T00:00:00Z